CINFENOAC

Details

Stereochemistry	ACHIRAL
Molecular Formula	C18H14O6
Molecular Weight	326.3002
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	1
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

OC(=O)COC1=CC=C(C=C1)C(=O)\C=C\C2=CC=C(C=C2)C(O)=O

InChI

InChIKey=HXSSCTOWBWPFEV-XCVCLJGOSA-N

InChI=1S/C18H14O6/c19-16(10-3-12-1-4-14(5-2-12)18(22)23)13-6-8-15(9-7-13)24-11-17(20)21/h1-10H,11H2,(H,20,21)(H,22,23)/b10-3+

HIDE SMILES / InChI

Molecular Formula	C18H14O6
Molecular Weight	326.3002
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	1
Optical Activity	NONE

Description
Sources: https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=19800226&DB=EPODOC&locale=en_EP&CC=US&NR=4190671A&KC=A&ND=4

Cinfenoac is a chalcone derivative patented by a pharmaceutical company Biorex Laboratories from the UK. The compound is claimed for the treatment of inflammatory and allergic conditions, as well as for the treatment of the ulcerous condition of the gastrointestinal tract.

Approval Year

Substance Class	Chemical Created by `admin` on `Mon Mar 31 18:26:50 GMT 2025` Edited by `admin` on `Mon Mar 31 18:26:50 GMT 2025`
Record UNII	055F0R97NJ
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

CINFENOAC

Official Name

English

P-(2-(.ALPHA.-CARBOXY-P-ANISOYL)VINYL)BENZOIC ACID

Preferred Name

English

cinfenoac [INN]

Common Name

English

Code System Code Type Description

NCI_THESAURUS

C171849